Showing 13,221 - 13,240 results of 31,940 for search '(( 50 ((mean decrease) OR (a decrease)) ) OR ( 5 ((fold decrease) OR (nn decrease)) ))', query time: 0.97s Refine Results
  1. 13221
  2. 13222
  3. 13223
  4. 13224

    PCAIs inhibit NCI-H23 cell line viability. by Matthew D. Gregory (19929096)

    Published 2024
    “…Of the 17 PCAIs tested, compounds NSL-YHJ-2-27 and NSL-YHJ-2-46 showed the most potency with EC<sub>50</sub> values of 2.7 and 3.3 μM, respectively. …”
  5. 13225

    PCAIs disrupt actin filaments in NCI-H23 cells. by Matthew D. Gregory (19929096)

    Published 2024
    “…Of the 17 PCAIs tested, compounds NSL-YHJ-2-27 and NSL-YHJ-2-46 showed the most potency with EC<sub>50</sub> values of 2.7 and 3.3 μM, respectively. …”
  6. 13226

    PCAIs suppress 3D NCI-H23 cell invasion. by Matthew D. Gregory (19929096)

    Published 2024
    “…Of the 17 PCAIs tested, compounds NSL-YHJ-2-27 and NSL-YHJ-2-46 showed the most potency with EC<sub>50</sub> values of 2.7 and 3.3 μM, respectively. …”
  7. 13227

    PCAIs suppress NCI-H23 cancer cell migration. by Matthew D. Gregory (19929096)

    Published 2024
    “…Of the 17 PCAIs tested, compounds NSL-YHJ-2-27 and NSL-YHJ-2-46 showed the most potency with EC<sub>50</sub> values of 2.7 and 3.3 μM, respectively. …”
  8. 13228

    PCAIs induce apoptosis in NCI-H23 cells. by Matthew D. Gregory (19929096)

    Published 2024
    “…Of the 17 PCAIs tested, compounds NSL-YHJ-2-27 and NSL-YHJ-2-46 showed the most potency with EC<sub>50</sub> values of 2.7 and 3.3 μM, respectively. …”
  9. 13229
  10. 13230
  11. 13231

    Prevaelnce of different pathogens by location. by Amete Mihret Teshale (12072758)

    Published 2025
    “…<div><p>Diarrheal illness remains a major global health challenge, causing millions of deaths annually. …”
  12. 13232
  13. 13233
  14. 13234
  15. 13235
  16. 13236
  17. 13237
  18. 13238

    Image_3_Clinical Outcomes and Complications of Preoperative Embolization for Intracranial Giant Meningioma Tumorectomy: A Retrospective, Observational, Matched Cohort Study.tif by Yi Yin (448434)

    Published 2022
    “…We did not find any significant differences of estimated blood loss (600.00 (400) vs. 500.00 (500.00) ml, p = 0.31), decrease of HGB level (30.81 ± 15.82 vs. 26.59 ± 12.90 g/L, p = 0.09), gross total resection rate (74.24% vs. 77.27%, p = 0.68), surgical time (302.50 (136) vs. 300.00 (72) min, p = 0.48), blood transfusion rates (53.03% vs. 42.42%, p = 0.35), blood transfusion volume [650.00 (657.50) vs. 535.00 (875.00) ml, p = 0.63] between the embolization group and nonembolization group. …”
  19. 13239
  20. 13240

    Image_1_Clinical Outcomes and Complications of Preoperative Embolization for Intracranial Giant Meningioma Tumorectomy: A Retrospective, Observational, Matched Cohort Study.tif by Yi Yin (448434)

    Published 2022
    “…We did not find any significant differences of estimated blood loss (600.00 (400) vs. 500.00 (500.00) ml, p = 0.31), decrease of HGB level (30.81 ± 15.82 vs. 26.59 ± 12.90 g/L, p = 0.09), gross total resection rate (74.24% vs. 77.27%, p = 0.68), surgical time (302.50 (136) vs. 300.00 (72) min, p = 0.48), blood transfusion rates (53.03% vs. 42.42%, p = 0.35), blood transfusion volume [650.00 (657.50) vs. 535.00 (875.00) ml, p = 0.63] between the embolization group and nonembolization group. …”